HCA Healthcare Inc. (NYSE:HCA) went down by -4.22% from its latest closing price compared to the recent 1-year high of $279.02. The company’s stock price has collected -2.18% of loss in the last five trading sessions. The Wall Street Journal reported on 08/08/22 that Hiring Gets Easier for Some Employers Despite Hot Job Market
Is It Worth Investing in HCA Healthcare Inc. (NYSE :HCA) Right Now?
HCA Healthcare Inc. (NYSE:HCA) scored a price-to-earnings ratio above its average ratio, recording 14.27 x from its present earnings ratio. Plus, the 36-month beta value for HCA is at 1.65. Opinions of the stock are interesting as 18 analysts out of 26 who provided ratings for HCA Healthcare Inc. declared the stock was a “buy,” while 3 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $260.30, which is $12.87 above the current price. HCA currently public float of 210.77M and currently shorts hold a 1.31% ratio of that float. Today, the average trading volume of HCA was 1.27M shares.
HCA’s Market Performance
HCA stocks went down by -2.18% for the week, with a monthly jump of 4.03% and a quarterly performance of 28.49%, while its annual performance rate touched 6.20%. The volatility ratio for the week stands at 3.27% while the volatility levels for the past 30 days are set at 2.26% for HCA Healthcare Inc. The simple moving average for the period of the last 20 days is 1.08% for HCA stocks with a simple moving average of 17.53% for the last 200 days.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with BMO Capital Markets repeating the rating for HCA by listing it as a “Underperform.” The predicted price for HCA in the upcoming period, according to BMO Capital Markets is $160 based on the research report published on July 06th of the previous year 2022.
Loop Capital, on the other hand, stated in their research note that they expect to see HCA reach a price target of $240. The rating they have provided for HCA stocks is “Buy” according to the report published on June 17th, 2022.
Bernstein gave a rating of “Outperform” to HCA, setting the target price at $271 in the report published on May 27th of the previous year.
HCA Trading at 4.92% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.44% of loss for the given period.
Volatility was left at 2.26%, however, over the last 30 days, the volatility rate increased by 3.27%, as shares surge +4.78% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.89% upper at present.
During the last 5 trading sessions, HCA fell by -2.18%, which changed the moving average for the period of 200-days by +0.88% in comparison to the 20-day moving average, which settled at $250.54. In addition, HCA Healthcare Inc. saw 5.30% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at HCA starting from MOORE A BRUCE JR, who sale 10,000 shares at the price of $224.07 back on Nov 11. After this action, MOORE A BRUCE JR now owns 30,807 shares of HCA Healthcare Inc., valued at $2,240,690 using the latest closing price.
Hall Charles J, the Group President of HCA Healthcare Inc., sale 9,838 shares at $223.50 during a trade that took place back on Oct 28, which means that Hall Charles J is holding 199,883 shares at $2,198,793 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- +16.47 for the present operating margin
- +16.47 for the gross margin
The net margin for HCA Healthcare Inc. stands at +11.84. Equity return is now at value -214.70, with 10.40 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.41.